Selected research
Industry Growth & Trends
Global Kidney Cancer Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Kidney Cancer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Kidney Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Kidney Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Kidney Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Kidney Cancer market include Aveo Pharmaceuticals, Bristol-Myers Squibb, Exelixis, Hikma Pharmaceuticals, Sun Pharmaceutical, Amgen, Bayer, Pfizer and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Kidney Cancer market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Kidney Cancer market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Kidney Cancer market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Kidney Cancer.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Kidney Cancer market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Kidney Cancer Market by Company
Aveo Pharmaceuticals
Bristol-Myers Squibb
Exelixis
Hikma Pharmaceuticals
Sun Pharmaceutical
Amgen
Bayer
Pfizer
Roche
Merck
Novartis
Eisai
Kidney Cancer Segment by Type
Targeted Therapy
Immunotherapy
Surgery
Other
Kidney Cancer Segment by Application
Renal Cell Carcinoma
Renal Pelvis Cancer
Other
Kidney Cancer Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Cancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kidney Cancer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Cancer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Kidney Cancer companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Therapy
- Immunotherapy
- Surgery
- Other
Applications
- Renal Cell Carcinoma
- Renal Pelvis Cancer
- Other
Companies covered
- Aveo Pharmaceuticals
- Bristol-Myers Squibb
- Exelixis
- Hikma Pharmaceuticals
- Sun Pharmaceutical
- Amgen
- Bayer
- Pfizer
- Roche
- Merck
- Novartis
- Eisai
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Kidney Cancer Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Kidney Cancer Market Size by Region (2021-2032)
- 1.4.1 Global Kidney Cancer Market Size by Region (2021-2026)
- 1.4.2 Global Kidney Cancer Market Size by Region (2027-2032)
- 1.5 Key Regions Kidney Cancer Market Size (2021-2032)
- 1.5.1 North America Kidney Cancer Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Kidney Cancer Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Kidney Cancer Market Size Growth Rate (2021-2032)
- 1.5.4 South America Kidney Cancer Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Kidney Cancer Market Size Growth Rate (2021-2032)
2 Kidney Cancer Market by Type
- 2.1 Type Introduction
- 2.1.1 Targeted Therapy
- 2.1.2 Immunotherapy
- 2.1.3 Surgery
- 2.1.4 Other
- 2.2 Global Kidney Cancer Market Size by Type
- 2.2.1 Global Kidney Cancer Market Size Overview by Type (2021-2032)
- 2.2.2 Global Kidney Cancer Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Kidney Cancer Market Size Forecasted by Type (2027-2032)
- 2.3 Global Kidney Cancer Market Size by Regions
- 2.3.1 North America Kidney Cancer Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Kidney Cancer Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Kidney Cancer Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Kidney Cancer Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Kidney Cancer Market Size Breakdown by Type (2021-2026)
3 Kidney Cancer Market by Application
- 3.1 Type Introduction
- 3.1.1 Renal Cell Carcinoma
- 3.1.2 Renal Pelvis Cancer
- 3.1.3 Other
- 3.2 Global Kidney Cancer Market Size by Application
- 3.2.1 Global Kidney Cancer Market Size Overview by Application (2021-2032)
- 3.2.2 Global Kidney Cancer Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Kidney Cancer Market Size Forecasted by Application (2027-2032)
- 3.3 Global Kidney Cancer Market Size by Regions
- 3.3.1 North America Kidney Cancer Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Kidney Cancer Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Kidney Cancer Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Kidney Cancer Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Kidney Cancer Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Kidney Cancer Industry Trends
- 4.2 Kidney Cancer Industry Drivers
- 4.3 Kidney Cancer Industry Opportunities and Challenges
- 4.4 Kidney Cancer Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Kidney Cancer Revenue (2021-2026)
- 5.2 Global Kidney Cancer Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Kidney Cancer Key Company Headquarters & Area Served
- 5.4 Global Kidney Cancer Company, Product Type & Application
- 5.5 Global Kidney Cancer Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Kidney Cancer Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Kidney Cancer Players Market Share by Revenue in 2025
- 5.6.3 2025 Kidney Cancer Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Aveo Pharmaceuticals
- 6.1.1 Aveo Pharmaceuticals Company Information
- 6.1.2 Aveo Pharmaceuticals Business Overview
- 6.1.3 Aveo Pharmaceuticals Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Aveo Pharmaceuticals Kidney Cancer Product Portfolio
- 6.1.5 Aveo Pharmaceuticals Recent Developments
- 6.2 Bristol-Myers Squibb
- 6.2.1 Bristol-Myers Squibb Company Information
- 6.2.2 Bristol-Myers Squibb Business Overview
- 6.2.3 Bristol-Myers Squibb Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Bristol-Myers Squibb Kidney Cancer Product Portfolio
- 6.2.5 Bristol-Myers Squibb Recent Developments
- 6.3 Exelixis
- 6.3.1 Exelixis Company Information
- 6.3.2 Exelixis Business Overview
- 6.3.3 Exelixis Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Exelixis Kidney Cancer Product Portfolio
- 6.3.5 Exelixis Recent Developments
- 6.4 Hikma Pharmaceuticals
- 6.4.1 Hikma Pharmaceuticals Company Information
- 6.4.2 Hikma Pharmaceuticals Business Overview
- 6.4.3 Hikma Pharmaceuticals Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Hikma Pharmaceuticals Kidney Cancer Product Portfolio
- 6.4.5 Hikma Pharmaceuticals Recent Developments
- 6.5 Sun Pharmaceutical
- 6.5.1 Sun Pharmaceutical Company Information
- 6.5.2 Sun Pharmaceutical Business Overview
- 6.5.3 Sun Pharmaceutical Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Sun Pharmaceutical Kidney Cancer Product Portfolio
- 6.5.5 Sun Pharmaceutical Recent Developments
- 6.6 Amgen
- 6.6.1 Amgen Company Information
- 6.6.2 Amgen Business Overview
- 6.6.3 Amgen Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Amgen Kidney Cancer Product Portfolio
- 6.6.5 Amgen Recent Developments
- 6.7 Bayer
- 6.7.1 Bayer Company Information
- 6.7.2 Bayer Business Overview
- 6.7.3 Bayer Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Bayer Kidney Cancer Product Portfolio
- 6.7.5 Bayer Recent Developments
- 6.8 Pfizer
- 6.8.1 Pfizer Company Information
- 6.8.2 Pfizer Business Overview
- 6.8.3 Pfizer Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Pfizer Kidney Cancer Product Portfolio
- 6.8.5 Pfizer Recent Developments
- 6.9 Roche
- 6.9.1 Roche Company Information
- 6.9.2 Roche Business Overview
- 6.9.3 Roche Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Roche Kidney Cancer Product Portfolio
- 6.9.5 Roche Recent Developments
- 6.10 Merck
- 6.10.1 Merck Company Information
- 6.10.2 Merck Business Overview
- 6.10.3 Merck Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Merck Kidney Cancer Product Portfolio
- 6.10.5 Merck Recent Developments
- 6.11 Novartis
- 6.11.1 Novartis Company Information
- 6.11.2 Novartis Business Overview
- 6.11.3 Novartis Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Novartis Kidney Cancer Product Portfolio
- 6.11.5 Novartis Recent Developments
- 6.12 Eisai
- 6.12.1 Eisai Company Information
- 6.12.2 Eisai Business Overview
- 6.12.3 Eisai Kidney Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Eisai Kidney Cancer Product Portfolio
- 6.12.5 Eisai Recent Developments
7 North America
- 7.1 North America Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Kidney Cancer Market Size by Country (2021-2026)
- 7.3 North America Kidney Cancer Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Kidney Cancer Market Size by Country (2021-2026)
- 8.3 Europe Kidney Cancer Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Kidney Cancer Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Kidney Cancer Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Kidney Cancer Market Size by Country (2021-2026)
- 10.3 South America Kidney Cancer Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Kidney Cancer Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Kidney Cancer Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst